Work

Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain.

Year: 2010

Type: article

Source: PubMed

Author: Antonino Cattaneo

Institution: European Brain Research Institute

Language: English

Topic: Pain Mechanisms and Treatments

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2236055221

FWCI: 10.41

Cites:

Cited by: 88

Related to: 10